Page last updated: 2024-12-06

cobaltous nitrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cobaltous nitrate: RN given refers to Co(+2) salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cobalt dinitrate : A cobalt salt in which the cobalt metal is in the +2 oxidation state and the counter-anion is nitrate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25000
CHEBI ID86209
MeSH IDM0085674

Synonyms (31)

Synonym
AKOS015833344
cobalt nitrate
cobalt(2+) nitrate
hsdb 238
cobalt(ii) nitrate
nitric acid, cobalt(2+) salt
einecs 233-402-1
cobalt bis(nitrate)
cobalt dinitrate
cobalt nitrate (co(no3)2)
cobaltous nitrate
nitric acid, cobalt salt
cobalt(2+) dinitrate
65w79bfd5v ,
10141-05-6
unii-65w79bfd5v
ec 233-402-1
nitric acid, cobalt(2+) salt (2:1)
14216-74-1
einecs 238-075-9
cobalt nitrate [who-dd]
cobaltous nitrate [mi]
cobaltous nitrate [hsdb]
cobalt nitrate salt
UFMZWBIQTDUYBN-UHFFFAOYSA-N
DTXSID9064970
CHEBI:86209
co(no3)2
Q414860
19154-72-4
cobalt(2+);dinitrate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The values obtained for the LD50 (7 days) were 133, 194, 198 and 279 mg of Co/kg respectively, when the salts were given orally."( [Acute toxicity and hematological and serum changes caused by various cobalt salts in rats].
Domingo, JL; Llobet, JM, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
inorganic nitrate salt
cobalt salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (26.67)18.7374
1990's1 (3.33)18.2507
2000's12 (40.00)29.6817
2010's8 (26.67)24.3611
2020's1 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.21 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index109.95 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (67.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.03%)4.05%
Observational0 (0.00%)0.25%
Other32 (96.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]